Market Tracker

05/25 8:13am ET

Myriad Genetics Inc (NASDAQ:MYGN)

20.47
Delayed Data
As of May 24
 -0.15 / -0.73%
Today’s Change
15.15
Today|||52-Week Range
35.35
+22.80%
Year-to-Date
No recent news for Myriad Genetics Inc.

Today’s Trading

Previous close20.62
Today’s open20.68
Day’s range20.43 - 20.78
Volume654,280
Average volume (3 months)1,475,817
Market cap$1.4B
Dividend yield--
Data as of 05/24/2017

Growth & Valuation

Earnings growth (last year)+58.33%
Earnings growth (this year)-37.55%
Earnings growth (next 5 years)-3.70%
Revenue growth (last year)+4.25%
P/E ratio45.5
Price/Sales2.98
Price/Book1.90

Competitors

 Today’s
change
Today’s
% change
AAAPAdvanced Accelerator...+0.19+0.50%
IMMUImmunomedics Inc-0.08-1.06%
QDELQuidel Corp+0.01+0.04%
--Quidel Corp+0.16+0.75%
Data as of 05/24/2017

Financials

Next reporting dateAugust 15, 2017
EPS forecast (this quarter)$0.27
Annual revenue (last year)$753.8M
Annual profit (last year)$125.3M
Net profit margin16.62%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Mark C. Capone
Executive Vice President-
International Operations
Gary A. King
Corporate headquarters
Salt Lake City, Utah

Forecasts